SIRT3 and idiopathic pulmonary fibrosis: Conversely, SIRT-3 serum levels were significantly increased in IPF patients compared to controls (median IPF 338 [230–500] pg/mL vs. controls 154 [99.8–246] pg/mL; p < 0.001) (Fig. 2b).